Page 33 - PRECONGRESS COURSE 06
P. 33
ESHRE PCC 6:
Ovarian Stimulation for IVF: Individualization and beyond:
The stimulation drug FSH: What do we need to know?
IMPLICATIONS FOR CLINICAL PRACTICE
Differences in Bioactivity of different FSH preparations
(Lombardi et al., Electrophoresis 2013; Yding Andersen, Reprod Biomed Online 2004)
Biopotency expressed ED 50 in Sertoli cells
14 12 10
8 6 4 2 0
Metrodin Metrodin HP Puregon Gonal-F
Page 29 of 258
PRECONGRESS COURSE 06 I GENEVA, SWITZERLAND – 2 JULY 2017 33
